Outcome of Board Meeting - Increase in Authorised Capital
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Achyut Healthcare's board approved raising the authorised capital from Rs. 24 crore to Rs. 26 crore to make room for future fundraising. It also cleared a preferential allotment of up to 58 lakh equity shares at Rs. 6 each (Rs. 1 face value plus Rs. 5 premium), raising up to Rs. 3.48 crore from promoter group entities and certain non-promoter investors. Q3 FY26 revenue from operations fell to Rs. 156.96 lakh from Rs. 254.65 lakh in the previous quarter, while net profit dropped sharply to Rs. 0.43 lakh from Rs. 12.10 lakh. For the nine months ended December 2025, revenue grew strongly to Rs. 720.83 lakh versus Rs. 212.66 lakh a year ago, but net profit slipped to Rs. 23.73 lakh from Rs. 38.59 lakh. The company also shifted its registered office within Ahmedabad and called an EGM for February 19, 2026 to seek shareholder approval. Separately, the stock recently migrated from the BSE SME platform to the BSE Mainboard effective January 2, 2026.
The preferential allotment is relatively small (Rs. 3.48 crore) and is being made mostly to promoter-related entities, so dilution for existing public shareholders is limited but the preferential price of Rs. 6 will serve as a benchmark for valuation. Weak Q3 sequential numbers and declining profitability despite higher nine-month revenue may concern short-term investors, though the Mainboard migration could improve liquidity and visibility over time.